65E-30732-01598
3 vaccinations
7 coded responses
41 check-ins
7 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 936 / CA
- Registered
- 2021-02-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-19
Registered in v-safe
-
2021-02-19
Dose 1 — Pfizer-BioNTech
-
2021-02-19
Survey response — day 0, dose 1MedDRA: Dizziness — Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Mild dizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-20
- 2021-02-21
- 2021-02-22
- 2021-02-23
- 2021-02-24
- 2021-02-25
- 2021-02-28
-
2021-03-05
Survey response — day 14, dose 1MedDRA: Fatigue — Feeling: Good · Be unable to do your normal daily activitiesFree text: Significant fatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-12
-
2021-03-19
Dose 2 — Pfizer-BioNTech
- 2021-03-19
-
2021-03-20
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Nausea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-21
- 2021-03-22
- 2021-03-23
- 2021-03-24
- 2021-03-25
- 2021-03-26
- 2021-04-02
- 2021-04-09
- 2021-04-16
- 2021-04-23
-
2021-04-30
Survey response — day 42, dose 2MedDRA: Dizziness — Feeling: GoodFree text: Intermittent LightheadednessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-18
Survey response — 3 months, dose 2MedDRA: Chest pain, Office visit, Palpitations — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Related to my heart issues. Significant palpitations and also chest pain · Healthcare visit (other): Doctor visitMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-18
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-25
- 2021-09-17
-
2021-10-04
Dose 3 — Pfizer-BioNTech
- 2021-10-04
-
2021-10-05
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain, Itching · Chills, Joint pains, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-06
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Fatigue or tiredness, Abdominal painAdult check-in
- 2021-10-07
- 2021-10-08
-
2021-10-09
Health check-in — days 1–6 daily, dose 3Feeling: Good · Joint pains, Fatigue or tirednessAdult check-in
-
2021-10-10
Health check-in — days 1–6 daily, dose 3Feeling: Good · Joint pains, Fatigue or tirednessAdult check-in
- 2021-10-11
-
2021-10-18
Survey response — day 14, dose 3MedDRA: Fatigue — Feeling: GoodFree text: FatigueMedDRA releases: 2024-11 · check-in free text available
- 2021-10-25
- 2021-11-01
- 2021-11-08
- 2021-11-15
- 2022-01-05
-
2022-04-04
Survey response — 6 months, dose 3MedDRA: Asthma, COVID-19, Fatigue, Malaise, Parosmia, Pre-existing disease, Taste disorder — Feeling: Good · Be unable to do your normal daily activitiesFree text: Since I got Covid, & I was very sick for almost a month, I have occasional bouts of bad fatigue. Also my taste/smell is off kilter. Liveable, but slightly off. Fortunately, my asthma which worsened during Covid, is back to my baseline asthma.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-04
Survey response — 12 months, dose 3MedDRA: Swelling — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: I have some left supraclavicular swelling. Getting it evaluated.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-04
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-10-06
- 2022-10-06
-
2022-10-06
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-10-06
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-19 | Pfizer-BioNTech | |
| 2 | 2021-03-19 | Pfizer-BioNTech | |
| 3 | 2021-10-04 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 successful
Free text
Release 4 — day 0, dose 1
Systemic reaction (other): Mild dizziness
Release 5 — day 14, dose 1
Symptoms: Significant fatigue
Release 8 — day 42, dose 2
Symptoms: Intermittent Lightheadedness
Release 9 — 3 months, dose 2
Symptoms: Related to my heart issues. Significant palpitations and also chest pain
Healthcare visit (other): Doctor visit
Release 10 — day 14, dose 3
Symptoms: Fatigue
Release 11 — 6 months, dose 3
Symptoms: Since I got Covid, & I was very sick for almost a month, I have occasional bouts of bad fatigue. Also my taste/smell is off kilter. Liveable, but slightly off. Fortunately, my asthma which worsened during Covid, is back to my baseline asthma.
Release 12 — 12 months, dose 3
Symptoms: I have some left supraclavicular swelling. Getting it evaluated.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | Asthma | · | · | ✓ |
| SD | Chest pain | ✓ | ✓ | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dizziness | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Palpitations | ✓ | ✓ | ✓ |
| SD | Parosmia | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Swelling | · | · | ✓ |
| SD | Taste disorder | · | · | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release